Drug Tracking Talks Continue As Panel OKs FDA Fee Bill

Law360, New York (May 10, 2012, 1:53 PM EDT) -- A House panel on Thursday unanimously approved legislation authorizing the U.S. Food and Drug Administration's $2.8 billion user fee agreements, setting the bill up for a floor vote by the end of the month even as negotiations continue over a nationwide track-and-trace system for drugs.

After a brief and congenial markup session, the House Energy and Commerce Committee, which has jurisdiction over the FDA, approved the package in a vote of 46-0 with no amendments. A spokeswoman for House leaders said they hoped to have a...
To view the full article, register now.